Kuehn Law Encourages KAMN, SNCE, KRTX, and BATL Investors to Contact Law Firm NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek...

Kuehn Law Encourages SNCE, MGRC, VINE, and KRTX Investors to Contact Law Firm Kuehn Law probes SNCE, MGRC, VINE, KRTX mergers, seeking further disclosures and fairness for shareholders.

Kuehn Law Encourages AYX, EGLE, AMAM, and KRTX Investors to Contact Law Firm Kuehn Law probes AYX, EGLE, AMAM, KRTX mergers for shareholder rights, urging investors to contact for potential claims

Moore Kuehn, PLLC Encourages Investors of Karuna Therapeutics, Inc. to Contact Law Firm NEW YORK, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating whether certain officers and directors of Karuna Therapeutics, Inc....

Zai Lab and Karuna Therapeutics Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China Zai Lab obtains exclusive rights to develop and commercialize KarXT in Greater China Karuna to receive upfront cash payment of $35 million, up to $152 million in potential near- and long-term...